Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,193 stories, page 500 of 704

Advanced search

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT07711210: Efficacy and Safety of the ACC017-Based Antiretroviral Regimen in Treatment-Experienced Adults With HIV-1 Harboring Non-Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT07710872: Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT07710638: Efficacy of Ivermectin in the Treatment of Plane Warts

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT07710157: A Randomized Controlled, Two-arm (1:1 Ratio) Phase IIa Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With de Novo Minimal Change Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT07710066: Analysis of Weaning of Analgosedation and Kinetics of Emergence in Critically Ill Patients

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT07704333: Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT07703709: Colorectal Cancer Real-world Outcomes Study of Survival With Immunomodulator Plus Standard Anti-cancer Therapies

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT07505771: A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT07287098: A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT07222488: A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT07165028: A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT07064018: Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT06581146: A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT06565689: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT06513962: Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT06398444: A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT06370728: A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT06251310: SW-682 in Advanced Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT05971758: Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT05835310: An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT05706311: Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT05429632: Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT05108298: Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT05010018: A Mobile Application to Improve Procurement and Distribution of Healthful Foods & Beverages in Baltimore City

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT04395079: Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT03827941: Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT03804255: Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT03648905: Clinical Laboratory Evaluation of Chronic Autonomic Failure

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT02484404: Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT02311335: Genes Involved in Lipid Disorders

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT02091999: A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT01949662: Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT00481546: Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 17Researchclinicaltrials.govTier 1 · Trial registry

NCT00091871: A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy?

AOL.comOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Is This Biotech Stock a Buy Near Its 52-Week High?

AOL.comOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Dimerix Acquires DMX-652 Phase 2 Asset and Strengthens Kidney Disease Pipeline with Non-Dilutive Funding

KalkineOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Compounded GLP-1s: Why doctors worry and the FDA is cracking down

Stanford MedicineOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

UPS commits $48 million to 27 temperature-controlled cross-dock facilities for pharma and biotech

MarketScaleOriginal source

🇺🇰Jul 17Researchthelancet.comTier 2 · Direct publisher

[News] First Nations cancer inequalities in Canada

Lancet OncologyOriginal source

🇺🇰Jul 17Researchthelancet.comTier 2 · Direct publisher

[News] New guidelines to advocate healthy eating and physical activity in school settings in the Americas

Lancet OncologyOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Telix Completes Patient Enrollment in TLX591-Px (Illuccix®) Japan Phase 3 Study

The Manila TimesOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Lilly offers up to $3.8 billion for AtaiBeckley in bet on ‘God molecule’ found in toad venom

drugdiscoverytrends.comOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene Slides 20% Ahead of U.S. TG-C Phase 3 Results

Seoul Economic DailyOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Takeda’s daily pill helped clear psoriasis on palms and soles for about 70%

Stock TitanOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

How FDA Can Speed Drug Innovation Without Cutting Corners

U.S. Chamber of CommerceOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

FDA Approves Merck’s Lipfendra, First Oral PCSK9 Drug to Match Injectables

The Eastern HeraldOriginal source

🇺🇸Jul 17Industrycryoport.comTier 1 · Company source

What it Takes to Launch a Modern Supply Chain Operation

CryoportOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Compass Pathways study shows minimal interaction in psilocybin trials

Investing.com UKOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Drug repurposing: Stakeholders say FDA should act within its authority, avoid disincentives

RAPSOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

UBS Michael Yee talks biotech M&A outlook

CNBCOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates Axsome stock rating on FDA filing

Investing.com UKOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

CDER plans new guidance on AI, electronic safety report submissions, and more

RAPSOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site

GuruFocusOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

FDA Accepts NDA for AXS-12 in Cataplexy Associated With Narcolepsy

HMP Global Learning NetworkOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Mumbai food safety crackdown: FDA suspends licences of Shalimar, Noor Mohammadi and Rehmania restaurants

MSNOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Gates MRI, Serum Institute sign deal to manufacture novel TB vaccine candidate

The New Indian ExpressOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Houston ALS Biotech Coya Eyes 2028 Approval Path

Streetwise ReportsOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

BASIS KIDS Phase 3 Trial Releases Encouraging Interim Data on Marstacimab for Hemophilia A, B

Docwire NewsOriginal source

🌍Jul 17discoverynews.google.comTier 3 · Aggregated media

Kalshi Is Letting People Bet On Clinical Trials And FDA Drug Decisions

ForbesOriginal source